Your antibiotic could be making you sick!

The Food and Drug Administration (FDA) is warning that the antibiotic drug, Ketek, could cause liver failure. Ketek, a telithromycin, is used to treat acute upper respiratory tract diseases including forms of chronic bronchitis, haemophilus influenzae and Moraxella catarrhalis.

Ketek will now carry a warning about the rare reports of liver failure and severe injury, some of them fatal. The drug manufacturer Sanofi-Aventis is informing healthcare professionals about the revisions to the U.S. prescribing information. Please consult your physician to discuss your medical concerns, and do not discontinue any medication without proper medical supervision.

If you or a loved one has suffered liver failure after taking Ketek, please contact the experienced pharmaceutical injury lawyers at Brown & Crouppen by calling 1-866-991-4700.

Ketek is most frequently prescribed for patients with chronic bronchitis; acute bacterial sinusitis; and community acquired pneumonia of mild to moderate severity, including pneumonia caused by resistant strep infections.

The FDA has said that it could not determine how frequently Ketek was associated with adverse events, and concluded that since the drug’s benefits outweighs its risks it should stay on the market.

Patients on Ketek should be vigilant, and watch for these signs and symptoms of liver failure: fatigue, malaise, loss of appetite, nausea, yellow skin and dark-colored urine.

If you or someone you love has been injured after taking Ketek, you need an attorney familiar with pharmaceutical liability. Brown & Crouppen has represented many victims of defective drugs, and as our client, you will be backed by a team of legal professionals, medical experts and investigators who are committed to ensuring that your rights are protected.

The attorneys at Brown & Crouppen can help you make informed decisions about your legal rights. Call us Toll-Free: 1-866-991-4700 for your free legal consultation or save time with our online Contact Form.